Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi

Trijn Israëls1, Marianne D van de Wetering, Peter Hesseling

  • 1Department of Paediatrics, College of Medicine, University of Malawi, Blantyre, Malawi. trijnisraels@hotmail.com

Insights

Malnutrition in children with Burkitt lymphoma significantly increases the risk of severe neutropenia and treatment-related deaths. Treatment protocols must adapt to nutritional status to improve outcomes in these vulnerable pediatric cancer patients.

Area of Science:

  • Pediatric Oncology
  • Infectious Disease Management
  • Global Health

Background:

  • Infection in neutropenic children is a critical factor in cancer treatment morbidity and mortality.
  • Malnutrition is prevalent in children with cancer in developing countries, impacting treatment.
  • Burkitt lymphoma treatment in Malawi uses a local protocol with limited toxicity.

Purpose of the Study:

  • To evaluate the incidence and outcomes of febrile neutropenia during Burkitt lymphoma treatment.
  • To assess the association between malnutrition at diagnosis and febrile neutropenia.
  • To determine treatment-related mortality in this pediatric cohort.

Main Methods:

  • Documented nutritional status (Arm Muscle Area) of pediatric Burkitt lymphoma patients.
  • Monitored febrile and/or neutropenic episodes and antibiotic use.
  • Recorded short-term outcomes, including treatment-related deaths.

Main Results:

  • 69% of patients presented with acute malnutrition (Arm Muscle Area < 5th percentile).
  • Malnutrition strongly correlated with profound neutropenia (OR 12, P=0.012), even after controlling for confounders.
  • All cases of profound neutropenia, prolonged neutropenia, and treatment-related deaths occurred in malnourished patients.

Conclusions:

  • Acute malnutrition at diagnosis is significantly linked to increased treatment-related profound neutropenia.
  • Chemotherapy intensity should be adjusted based on nutritional status and supportive care.
  • The local Burkitt lymphoma treatment protocol in Malawi has a 5% treatment-related mortality rate.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...